Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: A systematic review and meta-analysis

Gut

Volumn 65, Issue 12, 2016, Pages 1951-1959

  Valentin, Nelson ^a   Camilleri, Michael ^a   Altayar, Osama ^b   Vijayvargiya, Priya ^a   Acosta, Andres ^a   Nelson, Alfred D ^a   Murad, M Hassan ^c  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

BILE ACID; DIARRHOEA; FUNCTIONAL BOWEL DISORDER; IRRITABLE BOWEL SYNDROME

Indexed keywords

BILE ACID; EPITESTOSTERONE; FIBROBLAST GROWTH FACTOR 19; BIOLOGICAL MARKER;

75 SELENIUM HOMOTAUROCHOLIC ACID TEST; BILE ACID DIARRHEA; BILE ACID EXCRETION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIARRHEA; DISEASE SEVERITY; ENTEROPATHY; FUNCTIONAL BOWEL DISORDER; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; STEROID BLOOD LEVEL; SYSTEMATIC REVIEW; URINE LEVEL; CHRONIC DISEASE; COMPLICATION; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; IRRITABLE BOWEL SYNDROME; METABOLISM; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

BILE ACIDS AND SALTS; BIOMARKERS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; EVIDENCE-BASED MEDICINE; HUMANS; IRRITABLE BOWEL SYNDROME; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84941670697     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309889     Document Type: Review

References (60)

1. Fromm H, Malavolti M. Bile Acid-Induced Diarrhea. Clin Gastroenterol 1986;15:567-82.
2. al-Hadrani A, Lavelle-Jones M, Kennedy N, et al. Bile acid malabsorption in patients with post-vagotomy diarrhoea. Ann Chir Gynaecol 1992;81:351-3.
3. Wright JW, Lovell LA, Gemmell HG, et al. SeHCAT retention values as measured with a collimated and an uncollimated gamma camera: a method comparison study. Nucl Med Commun 2013;34:718-21.
4. Axelson M, Aly A, Sjovall J. Levels of 7-Alpha-Hydroxy-4-Cholesten-3-One in Plasma Reflect Rates of Bile-Acid Synthesis in Man. FEBS Lett 1988;239:324-8.
5. Galman C, Arvidsson I, Angelin B, et al. Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. J Lipid Res 2003;44:859-66.
6. Galman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 2005;129:1445-53.
7. Wedlake L, A'Hern R, Russell D, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009;30:707-17.
8. Vijayvargiya P, Camilleri M, Shin A, et al. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol 2013;11:1232-9.
9. Ford AC, Bercik P, Morgan DG, et al. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria. Aliment Pharmacol Ther 2014;39:312-21.
10. Locke GR III, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005;17:29-34.
11. Halder SL, Locke GR III, Schleck CD, et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007;133:799-807.
12. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-12.
13. Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2:653-4.
14. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
15. Bajor A, Tornblom H, Rudling M, et al. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut 2015;64:84-92.
16. Munn Z, Moola S, Riitano D, et al. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag 2014;3:123-8.
17. Aziz I, Mumtaz S, Bholah H, et al. High prevalence of idiopathic bile acid diarrhea among patients with diarrhea-predominant irritable bowel syndrome based on Rome III criteria. Clin Gastroenterol Hepatol 2015;13:1650-5, e2.
18. Borghede MK, Schlutter JM, Agnholt JS, et al. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea. Eur J Intern Med 2011;22:e137-40.
19. Brydon WG, Nyhlin H, Eastwood MA, et al. Serum 7 alpha-hydroxy-4-cholesten- 3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol 1996;8:117-23.
20. Brydon WG, Culbert P, Kingstone K, et al. An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea. Can J Gastroenterol 2011;25:319-23.
21. Camilleri M, Nadeau A, Tremaine WJ, et al. Measurement of serum 7alpha-hydroxy- 4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009;21:734-e43.
22. Camilleri M, Shin A, Busciglio I, et al. Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterology & Motility 2014;26:1677-85.
23. Eusufzai S. Bile acid malabsorption in patients with chronic diarrhoea. Scandinavian Journal of Gastroenterology 1993;28:865-8.
24. Fernandez-Banares F, Esteve M, Salas A, et al. Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci 2001;46:2231-8.
25. Fernandez-Banares F, Esteve M, Salas A, et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol 2007;102:2520-8.
26. Ford GA, Preece JD, Davies IH, et al. Use of the SeHCAT test in the investigation of diarrhoea. Postgrad Med J 1992;68:272-6.
27. Galatola G, Ferraris R, Pellerito R, et al. The prevalence of bile acid malabsorption in irritable bowel syndrome and the effect of cholestyramine: An uncontrolled open multicentre study. European Journal of Gastroenterology and Hepatology 1992;4:533-7.
28. Gracie DJ, Kane JS, Mumtaz S, et al. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 2012;24:983-e538.
29. Gray JA, Robinson M. Bile acid malabsorption: a review of sehcat testing in belfast. Gut 2013;62:A20.
30. Hashim A, Paulon E, Ahmed M. Bile acid malabsorption: an evaluation of current practice. Gut 2012;61:A243.
31. Kok B, Mistry A, Malhotra R, et al. Abdominal pain distinguishes idiopathic bile acid malabsorption (BAM) from diarrhoea-predominant irritable bowel syndrome (IBS-D). Gut 2013;62:A123.
32. Kumar L, Jamshed B, Emmanuel A. An Audit of Clinical Outcomes of Sehcat Study in Patients with Chronic Diarrhoea. Gut 2013;62:A284-A.
33. Kurien M, Evans KE, Leeds JS, et al. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scand J Gastroenterol 2011;46:818-22.
34. Maisterra S, Vilardell CP, Notta PC, et al. Bile acid malabsorption in the diagnosis of chronic diarrhea. Gastroenterology 2012;1:S268.
35. Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J (Clin Res Ed) 1985;290:665-8.
36. Muller M, Willen R, Stotzer PO. Colonoscopy and SeHCAT for investigation of chronic diarrhea. Digestion 2004;69:211-18.
37. Notta P, Martinez Pimienta G, Martin-Comin J, et al. Abdominal retention index of 75SeHCAT according to response to treatment with resincolestiramina. Eur J Nucl Med Mol Imaging 2014;41:S356.
38. Orekoya O, McLaughlin J, Leitao E, et al. Response to bile acid sequestrants is poor in patients with equivocal SeHCAT results. Gut 2012;61:A347.
39. Pattni SS, Brydon WG, Dew T, et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther 2013;38:967-76.
40. Rossel P, Sortsoe Jensen H, Qvist P, et al. Prognosis of adult-onset idiopathic bile acid malabsorption. Scandinavian Journal of Gastroenterology 1999;34: 587-90.
41. Rudberg U, Nylander B. Radiological bile acid absorption test (75)SeHCAT in patients with diarrhoea of unknown cause. Acta Radiol 1996;37:672-5.
42. Sauter GH, Munzing W, von Ritter C, et al. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci 1999;44:14-9.
43. Sciarretta G, Fagioli G, Furno A, et al. 75SeHCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 1987;28:970-5.
44. Sciarretta G, Furno A, Morrone B, et al. Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study. Am J Gastroenterol 1994;89:1058-61.
45. Shivaji UN, Chowdhury FU, Ford AC. Prevalence of bile acid malabsorption as a cause of diarrhoea in consecutive new patient referrals to a gastroenterology clinic. Gastroenterology 2014;1:S-706.
46. Sinha L, Liston R, Testa HJ, et al. Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to cholestyramine. Aliment Pharmacol Ther 1998;12:839-44.
47. Smith MJ, Cherian P, Raju GS, et al. Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond 2000;34:448-51.
48. Thomsen LH, Arveschough AK, Gustenhoff P, et al. [SeHCAT scanning in bile acid malabsorption]. Ugeskr Laeger 1998;160:5362-5.
49. Ung KA, Kilander AF, Lindgren A, et al. Impact of bile acid malabsorption in steatorrhoea and symptoms in patients with chronic diarrhoea. Eur J Gastroenterol Hepatol 2000;12:541-7.
50. Wildt S, Norby Rasmussen S, Lysgard Madsen J, et al. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test. Scandinavian Journal of Gastroenterology 2003;38:826-30.
51. Wong BS, Camilleri M, Carlson P, et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2012;10:1009-15.e3.
52. Walters JR. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. Expert Rev Gastroenterol Hepatol 2010;4:561-7.
53. Mustalahti K, Catassi C, Reunanen A, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010;42:587-95.
54. Bingley PJ, Williams AJ, Norcross AJ, et al. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ 2004;328:322-3.
55. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003;52:960-5.
56. Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol 2012;107:1538-44; quiz 7, 45.
57. Sciarretta G, Vicini G, Fagioli G, et al. Use of 23-Selena-25-Homocholyltaurine to Detect Bile-Acid Malabsorption in Patients with Ileal Dysfunction or Diarrhea. Gastroenterology 1986;91:1-9.
58. Thaysen EH, Orholm M, Arnfred T, et al. Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue. Gut 1982;23:862-5.
59. Abrahamsson H, Ostlund-Lindqvist AM, Nilsson, et al. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scandinavian Journal of Gastroenterology 2008;43:1483-8.
60. Camilleri M, Acosta A, Busciglio I, et al. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2015;41:438-48.